Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Patient characteristics of long-term responders to mogamulizumab: results from the MAVORIC study. European journal of cancer (Oxford, England : 1990) Kim, Y. H., Khodadoust, M., de Masson, A., Moins-Teisserenc, H., Ito, T., Dwyer, K., Herr, F., Bagot, M. 2021; 156 Suppl 1: S48-S49
View details for DOI 10.1016/S0959-8049(21)00715-2
View details for PubMedID 34649658